Some insurers require patients and oncologists to use drugs delivered by their preferred third-party pharmacies (also referred to as specialty pharmacies) or make patients face higher out-of-pocket costs. This is called "white" or "brown" bagging, depending on how it is mandated, and these policies interfere with oncologists’ ability to treat patients safely, which may put them at greater risk of medical challenges. COA strongly opposes white and brown bagging policies. Oncologists—not insurers—should be making treatment decisions on behalf of their patients.
Please join our next Advocacy Chat on Wednesday, October 14th from 12-12:30 pm ET as Rose Gerber, COA’s Director of Patient Advocacy and Education, and our special guest Barbara L. McAneny, MD, a board-certified medical oncologist and hematologist from Albuquerque, N.M., immediate past president of the American Medical Association (AMA), and a long-serving COA board member, as she discusses the challenges white and brown bagging poses for patients and oncologists.